Logo
x

Search

Subscribe Now

accent therapeutics

Accent Therapeutics to Highlight Preclinical Data of ATX-559 and ATX-295 at AACR 2025

Accent Therapeutics to Highlight Preclinical Data of ATX-559 and ATX-295 at AACR 2025

  • March 26, 2025
Accent Therapeutics Receives the US FDA’s IND Approval of ATX-559 for Treating Breast Cancer

Accent Therapeutics Receives the US FDA’s IND Approval of ATX-559 for Treating Breast Cancer

  • October 25, 2024
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.